Interestingly, simvastatin reduced TNF-α-induced synthesis of Cysteine-rich 61 (Cyr61) and chemokine ligand 2 (CCL2) [74] that are potential osteolytic mediators in inflammatory bone diseases, in human OB, thereby decreasing bone loss. The gene discussed is CCN1; the disease is bone inflammation disease.